Current Alzheimer Research

Editor-in-Chief

Prof. Debomoy K. Lahiri
(16607 citations)
Neuroscience Research Center
Indianapolis, IN 46202
(USA)

Nobel Laureates on Editorial Board

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Back

Become EABM
Become Reviewer

Editorial [Hot Topic:Advances in Alzheimer Therapy: Understanding Pharmacological Approaches to the Disease (Guest Editors: Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig)] promotion: free to download

Volume:6   Issue: 2
Pp: 83-85
Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig
DOI: 10.2174/156720509787602924

Cholinesterase Inhibitors and Beyond

Volume:6   Issue: 2
Pp: 86-96
Giancarlo Pepeu and Maria Grazia Giovannini
DOI: 10.2174/156720509787602861

Responders to ChEI Treatment of Alzheimers Disease Show Restitution of Normal Regional Cortical Activation

Volume:6   Issue: 2
Pp: 97-111
Annalena Venneri, William J. McGeown and Michael F. Shanks
DOI: 10.2174/156720509787602933

M1 Agonists as a Potential Disease-Modifying Therapy for Alzheimers Disease

Volume:6   Issue: 2
Pp: 112-117
Antonella Caccamo, Abraham Fisher and Frank M. LaFerla
DOI: 10.2174/156720509787602915

GEPT Extract Reduces Aβ Deposition by Regulating the Balance Between Production and Degradation of Aβ in APPV717I Transgenic Mice

Volume:6   Issue: 2
Pp: 118-131
Jinzhou Tian, Jing Shi, Leiming Zhang, Junxiang Yin, Quan Hu, Yi Xu, Shuli Sheng, Pengwen Wang, Ying Ren, Rong Wang and Yongyan Wang
DOI: 10.2174/156720509787602942

Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form

Volume:6   Issue: 2
Pp: 132-136
Kazuhiro Ito, Ken-Ichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Kei-Ichi Yamamoto, Erika Kitajima, Toshiki Idomoto, Toshie Nagatomo and Hiroshi Mori
DOI: 10.2174/156720509787602889

Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders open access plus

Volume:6   Issue: 2
Pp: 144-151
Bruno Vellas, R. Black, Leon J. Thal, Nick C. Fox, M. Daniels, G. McLennan, C. Tompkins, C. Leibman, M. Pomfret and Michael Grundman
DOI: 10.2174/156720509787602852

Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease

Volume:6   Issue: 2
Pp: 152-157
Karim Belarbi, Katharina Schindowski, Sylvie Burnouf, Raphaelle Caillierez, Marie-Eve Grosjean, Dominique Demeyer, Malika Hamdane, Nicolas Sergeant, David Blum and Luc Buee
DOI: 10.2174/156720509787602843

Development of a Non Invasive NGF-Based Therapy for Alzheimers Disease

Volume:6   Issue: 2
Pp: 158-170
Sonia Covaceuszach, Simona Capsoni, Gatsuella Ugolini, F. Spirito, D. Vignone and Antonio Cattaneo
DOI: 10.2174/156720509787602870

Natural Non-Trasgenic Animal Models for Research in Alzheimers Disease open access plus

Volume:6   Issue: 2
Pp: 171-178
Manuel Sarasa and Pedro Pesini
DOI: 10.2174/156720509787602834

Structural and Functional MRI in Mild Cognitive Impairment

Volume:6   Issue: 2
Pp: 179-185
Maija Pihlajamaki, Anne M. Jauhiainen and Hilkka Soininen
DOI: 10.2174/156720509787602898